1. Home
  2. HOTH vs SPPL Comparison

HOTH vs SPPL Comparison

Compare HOTH & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • SPPL
  • Stock Information
  • Founded
  • HOTH 2017
  • SPPL 2016
  • Country
  • HOTH United States
  • SPPL Singapore
  • Employees
  • HOTH N/A
  • SPPL N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • SPPL
  • Sector
  • HOTH Health Care
  • SPPL
  • Exchange
  • HOTH Nasdaq
  • SPPL Nasdaq
  • Market Cap
  • HOTH 18.0M
  • SPPL 19.5M
  • IPO Year
  • HOTH 2019
  • SPPL 2023
  • Fundamental
  • Price
  • HOTH $1.16
  • SPPL $3.71
  • Analyst Decision
  • HOTH Strong Buy
  • SPPL
  • Analyst Count
  • HOTH 2
  • SPPL 0
  • Target Price
  • HOTH $4.50
  • SPPL N/A
  • AVG Volume (30 Days)
  • HOTH 316.4K
  • SPPL 3.8K
  • Earning Date
  • HOTH 11-12-2025
  • SPPL 01-01-0001
  • Dividend Yield
  • HOTH N/A
  • SPPL N/A
  • EPS Growth
  • HOTH N/A
  • SPPL N/A
  • EPS
  • HOTH N/A
  • SPPL N/A
  • Revenue
  • HOTH N/A
  • SPPL $4,591,508.00
  • Revenue This Year
  • HOTH N/A
  • SPPL N/A
  • Revenue Next Year
  • HOTH N/A
  • SPPL N/A
  • P/E Ratio
  • HOTH N/A
  • SPPL N/A
  • Revenue Growth
  • HOTH N/A
  • SPPL 24.27
  • 52 Week Low
  • HOTH $0.66
  • SPPL $2.18
  • 52 Week High
  • HOTH $3.80
  • SPPL $16.80
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 38.64
  • SPPL 27.01
  • Support Level
  • HOTH $1.14
  • SPPL $4.80
  • Resistance Level
  • HOTH $1.22
  • SPPL $4.61
  • Average True Range (ATR)
  • HOTH 0.08
  • SPPL 0.32
  • MACD
  • HOTH -0.01
  • SPPL -0.18
  • Stochastic Oscillator
  • HOTH 38.57
  • SPPL 4.18

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Share on Social Networks: